Earnings History Data for Cullinan Therapeutics, Inc. (CGEM) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Cullinan Therapeutics, Inc.
Cullinan Management Inc. is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies for cancer patients. Cullinan Management Inc. is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | CGEM | Cullinan Therapeutics, Inc. | 926.00 | -0.69 | -0.78 | 0.00 | 15.54 | -0.94 (-5.70%) |
16.48 | 0.0 (0.00%) |
7.64 - 30.19 | 378,365 | 380,000 | 28,640 | |||
| 08-11-2023 | PM | CGEM | Cullinan Oncology | 419.00 | -0.91 | -0.91 | 0.00 | Cullinan Oncology GAAP EPS of -$0.91 beats by $0.03 [11/8/2023 8:48 AM] |
9.95 | 0.09 (0.91%) |
0.0 | 0.0 (0.00%) |
7.78 - 13.74 | 108,108 | 120,000 | 0 | ||
| 10-08-2023 | PM | CGEM | Cullinan Oncology, Inc. | 396.36 | -0.82 | -0.99 | -2.20 | Cullinan Oncology GAAP EPS of -$0.82 beats by $0.15 [8/10/2023 12:11 PM] |
10.82 | 0.53 (5.15%) |
10.29 | 0.0 (0.00%) |
7.78 - 14.37 | 176,643 | 150,000 | 14,116 | ||
| 11-05-2023 | AH | CGEM | Cullinan Oncology | 383.00 | -1.42 | -0.84 | 0.00 | Cullinan Oncology GAAP EPS of -$1.42 [5/11/2023 5:03 PM] |
9.74 | 0.12 (1.30%) |
9.62 | 0.0 (0.00%) |
7.78 - 15.89 | 468,622 | 140,000 | 4,426 | ||
| 09-03-2023 | PM | CGEM | Cullinan Oncology | 506.00 | -0.59 | -0.65 | 0.00 | Cullinan Oncology GAAP EPS of -$0.59 beats by $0.08 [3/9/2023 9:13 AM] |
11.12 | 0.06 (0.54%) |
0.0 | 0.0 (0.00%) |
7.30 - 15.89 | 168,011 | 190,000 | 0 | ||
| 14-11-2022 | PM | CGEM | Cullinan Oncology | 563.00 | -0.54 | -0.97 | 0.00 | Cullinan Oncology GAAP EPS of -$0.54 beats by $0.43 [11/14/2022 9:17 AM] |
12.63 | 0.35 (2.81%) |
12.50 | 0.21 (1.71%) |
7.30 - 21.54 | 95,638 | 150,000 | 600 | ||
| 10-08-2022 | PM | 6:45 AM ET (Aug 10) |
CGEM | Cullinan Oncology, Inc. | 651.59 | -2.20 | 5.47 | -0.36 | Cullinan Oncology GAAP EPS of $3.77 misses by $1.65 [8/10/2022 8:06 AM] |
13.88 | -0.17 (-1.21%) |
14.05 | 0.0 (0.00%) |
7.30 - 30.32 | 188,692 | 140,000 | 2,642 | |
| 17-03-2022 | PM | CGEM | Cullinan Oncology | 557.00 | -0.74 | -0.47 | 0.00 | Cullinan Oncology GAAP EPS of -$0.74 misses by $0.30 [3/17/2022 9:06 AM] |
12.79 | 0.54 (4.41%) |
12.51 | 0.26 (2.12%) |
11.52 - 43.60 | 153,343 | 200,143 | 8,675 | ||
| 10-08-2021 | PM | 6:30 AM ET (Aug 10) |
CGEM | Cullinan Oncology Inc. | 1,202 | -0.36 | -0.42 | 0.00 | Cullinan Oncology EPS beats by $0.05 [8/10/2021 6:47 AM] |
28.49 | 1.79 (6.70%) |
0.0 | 0.0 (0.00%) |
22.59 - 59.85 | 361,522 | 150,000 | 0 | |
| 14-05-2021 | PM | CGEM | Cullinan Oncology Inc. | 1,325 | N/A | 0.07 | 0.00 | Cullinan Oncology EPS misses by $0.07, misses on revenue [5/14/2021 6:41 AM] |
27.55 | -0.20 (-0.72%) |
27.75 | 0.0 (0.00%) |
27.01 - 59.85 | 170,535 | 130,000 | 3,910 | ||